genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Search
About GEN
Contact GEN
Subscribe/Update Preferences
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Novartis
Novartis Eliminating 8,000 Jobs in Global Restructuring
Drug Discovery
Common HIV Treatment Improves Cognition in Down Syndrome Mice
News
Terminator Upgrades Single-Cell RNA Sequencing Technology
Coronavirus
Epigenetics Links Severe Inflammatory Syndrome in Children to COVID Infection
Genetics
Novel Tissue Model May Help Harness the Liver’s Regenerative Abilities
Insights
All
Trends for 2020
Trends for 2021
Bioprocessing
Capturing Cells with Droplet Microfluidics
Antibiotics
Gene and Cell Therapies Need New Pricing Models
Bioprocessing
hMSCs are Efficient Factories to Produce Butyrylcholinesterase
Bioprocessing
Biopharma Digitization Impacting the Entire Supply Chain
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
A-Lists
Top 10 RNA-Based Biopharmas
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Home
Metabolic Disorders
Metabolic Disorders
Diabetes
Lysosomal Storage Disease
Obesity
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Metabolic Disorders
Intermittent Fasting Boosts Fat Burning and Improves Metabolic Function
GPCRs
Rule of Seven: Septerna Aims to Uncover GPCRs with $100M Series A
Metabolic Disorders
Court Vacates Temporary Restraining Order Against Lilly in Case Filed by Amylin
Metabolic Disorders
Protalix’ Gaucher’s Therapy Demonstrated Positive Results in Phase III
Metabolic Disorders
The Missing Link That Connects Gum Disease to Inflammatory Diseases
Metabolic Disorders
Ranbaxy Launches Generic Lipitor in the U.S.
Metabolic Disorders
Diamyd Medical Selects Cytiva’s FlexFactory Platform
Metabolic Disorders
BMS Nabs Global Rights to Ambrx’ Fibroblast Growth Factor and Relaxin...
Metabolic Disorders
Missing Link Points to New Diabetes Target
Metabolic Disorders
Eisai Pays Arena $50M Up Front for U.S. Rights to FDA-Submitted...
Metabolic Disorders
FDA Okays Novartis’ Hypertension Combination Therapy
Metabolic Disorders
Trial Shows Dangers of Combining Novartis’ Aliskiren with ACE-Inhibitor or ARB
Metabolic Disorders
MannKind’s Inhaled Insulin Shows Advantages over Injected Insulin
Metabolic Disorders
GSK Halts Enrollment for Postmarketing Avandia Trial as FDA Reviews Safety
Metabolic Disorders
Arena, Eisai Win FDA Okay for Obesity Drug
1
2
3
...
105
Page 1 of 105
Scroll Up
![Preclinical programs for the treatment of type 2 diabetes and heart failure are based on Ambrx’ amino acid-based protein modification platform.[© Gerhard Seybert - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Sept22_2011_23348714_SugarHeartSyringe_BMSAmbrxDiabetesCardioDeal2223913272-324x160.jpg "BMS Nabs Global Rights to Ambrx’ Fibroblast Growth Factor and Relaxin Candidates for $24M")
![Agency has until mid October to review NDA for lorcaserin. [© djma - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/July1_2010_11840039_FeetScaleWeightLossDrugsOnFloor_EisaiArenaObesityDrug1271791612-324x160.jpg "Eisai Pays Arena $50M Up Front for U.S. Rights to FDA-Submitted Obesity Therapy")
![European agency also reviewing risks of diabetes drug in light of recent studies. [© vishnukumar - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/July22_2010_19004692_HeartEKGMaleSilhouette_GSKHaltsTakingNewParticipantsInAvandiaTrial2032351032-324x160.jpg "GSK Halts Enrollment for Postmarketing Avandia Trial as FDA Reviews Safety")